PAM
GILD icon

Parvin Asset Management’s Gilead Sciences GILD Stock Holding History

Parvin Asset Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.3K Hold
200
– – 0.02% 243
2026
Q1 		$27.9K Hold
200
– – 0.02% 239
2025
Q4 		$24.5K Sell
200
-550
-73% -$66.8K 0.02% 235
2025
Q3 		$83.3K Hold
750
– – 0.07% 173
2025
Q2 		$83.2K Sell
750
-4
-0.5% -$426 0.08% 161
2025
Q1 		$84.5K Sell
754
-46
-6% -$4.75K 0.09% 157
2024
Q4 		$73.9K Buy
+800
New +$72K 0.08% 173

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Parvin Asset Management's GILD Position: Q2 2026 in Review

Parvin Asset Management held its Gilead Sciences (GILD) position steady in Q2 2026 at 200 shares worth $25.3K. The position accounts for 0.02% of the portfolio, ranked #243.

Parvin Asset Management first reported a position in GILD in Q4 2024 and has held it in 7 quarters since. The position peaked at $84.5K in Q1 2025. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Parvin Asset Management held 200 shares of Gilead Sciences worth $25.3K as of Q2 2026.
  • Parvin Asset Management left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.02% of Parvin Asset Management's portfolio in Q2 2026, its #243 holding.
  • Parvin Asset Management first reported a position in Gilead Sciences in Q4 2024 and has held it in 7 quarters since.
  • Parvin Asset Management's Gilead Sciences position peaked at $84.5K in Q1 2025.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Parvin Asset Management's 13F filing for Q2 2026, filed 17 Aug 2026.